LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $852,781 | +37.5% | 14,232 | +158.2% | 0.00% | 0.0% |
| Q1 2022 | $620,000 | -67.1% | 5,512 | -54.8% | 0.00% | -66.7% |
| Q4 2021 | $1,884,000 | +193.9% | 12,200 | +165.2% | 0.01% | +100.0% |
| Q3 2021 | $641,000 | -35.3% | 4,600 | -29.2% | 0.00% | -25.0% |
| Q1 2021 | $990,000 | +145.7% | 6,500 | +80.6% | 0.00% | +100.0% |
| Q2 2020 | $403,000 | -77.3% | 3,600 | -78.8% | 0.00% | -84.6% |
| Q4 2019 | $1,772,000 | +78.1% | 17,000 | +70.0% | 0.01% | +62.5% |
| Q3 2019 | $995,000 | -65.4% | 10,000 | -60.3% | 0.01% | -68.0% |
| Q2 2019 | $2,877,000 | +1244.4% | 25,200 | +1382.4% | 0.02% | +1150.0% |
| Q1 2019 | $214,000 | -14.4% | 1,700 | -7.8% | 0.00% | +100.0% |
| Q4 2018 | $250,000 | -92.6% | 1,844 | -85.0% | 0.00% | -94.4% |
| Q3 2018 | $3,376,000 | +41.7% | 12,300 | +7.0% | 0.02% | +38.5% |
| Q2 2018 | $2,383,000 | +11815.0% | 11,500 | +5650.0% | 0.01% | – |
| Q2 2015 | $20,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |